PL3233074T3 - Leczenie niealkoholowych stłuszczeniowych chorób wątroby - Google Patents

Leczenie niealkoholowych stłuszczeniowych chorób wątroby

Info

Publication number
PL3233074T3
PL3233074T3 PL15813009.6T PL15813009T PL3233074T3 PL 3233074 T3 PL3233074 T3 PL 3233074T3 PL 15813009 T PL15813009 T PL 15813009T PL 3233074 T3 PL3233074 T3 PL 3233074T3
Authority
PL
Poland
Prior art keywords
treatment
fatty liver
liver diseases
alcoholic fatty
alcoholic
Prior art date
Application number
PL15813009.6T
Other languages
English (en)
Inventor
Szabolcs PETER
Joseph Schwager
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of PL3233074T3 publication Critical patent/PL3233074T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/712—Vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL15813009.6T 2014-12-15 2015-12-14 Leczenie niealkoholowych stłuszczeniowych chorób wątroby PL3233074T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH19392014 2014-12-15
PCT/EP2015/079526 WO2016096685A1 (en) 2014-12-15 2015-12-14 Treatment for non-alcoholic fatty liver diseases

Publications (1)

Publication Number Publication Date
PL3233074T3 true PL3233074T3 (pl) 2023-02-06

Family

ID=54884019

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15813009.6T PL3233074T3 (pl) 2014-12-15 2015-12-14 Leczenie niealkoholowych stłuszczeniowych chorób wątroby

Country Status (9)

Country Link
US (3) US20180000775A1 (pl)
EP (1) EP3233074B1 (pl)
JP (1) JP6750831B2 (pl)
KR (1) KR20170093966A (pl)
CN (2) CN107205983A (pl)
BR (1) BR112017012811A2 (pl)
ES (1) ES2934132T3 (pl)
PL (1) PL3233074T3 (pl)
WO (1) WO2016096685A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170093966A (ko) 2014-12-15 2017-08-16 디에스엠 아이피 어셋츠 비.브이. 비-알콜성 지방간 질환의 치료
JP2022503799A (ja) 2018-10-22 2022-01-12 ディーエスエム アイピー アセッツ ビー．ブイ． 向上した酸化安定性を示す組成物
WO2022049168A1 (en) * 2020-09-04 2022-03-10 Dsm Ip Assets B.V. 17(s)-hdpa for metabolic-syndrome related disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
JP5552313B2 (ja) * 2006-11-01 2014-07-16 プロノヴァ・バイオファーマ・ノルゲ・アーエス 脂質化合物
EP3539560A1 (en) 2007-02-22 2019-09-18 Children's Hospital & Research Center at Oakland Fatty acid formulations and methods of use thereof
WO2009028457A1 (ja) * 2007-08-29 2009-03-05 Shinshu University 非アルコール性脂肪肝炎治療薬
WO2010040012A1 (en) 2008-10-01 2010-04-08 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
WO2011097273A1 (en) * 2010-02-02 2011-08-11 Martek Biosciences Corporation Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine
BR112012023139A2 (pt) * 2010-03-24 2018-06-26 Dong A Pharm Co Ltd composição farmacêutica para a prevenção ou o tratamento de doença do fígado gordo não alcóolico e o método para a prevenção ou tratamento de doença do fígado gordo não alcóolico usando a mesma.
ITMI20122088A1 (it) * 2012-12-06 2014-06-07 D M F Dietetic Metabolic Food S R L Composizione per la prevenzione ed il trattamento della steatosi epatica e/o della fibrosi cistica
JP2016518315A (ja) * 2013-03-13 2016-06-23 マティナス バイオファーマ インコーポレイテッド ω３ペンタエン酸組成物および使用方法
KR20170093966A (ko) 2014-12-15 2017-08-16 디에스엠 아이피 어셋츠 비.브이. 비-알콜성 지방간 질환의 치료

Also Published As

Publication number Publication date
CN115192568A (zh) 2022-10-18
US11026916B2 (en) 2021-06-08
EP3233074A1 (en) 2017-10-25
JP6750831B2 (ja) 2020-09-02
CN107205983A (zh) 2017-09-26
EP3233074B1 (en) 2022-09-28
US20180000775A1 (en) 2018-01-04
KR20170093966A (ko) 2017-08-16
WO2016096685A1 (en) 2016-06-23
ES2934132T3 (es) 2023-02-17
US20190054063A1 (en) 2019-02-21
BR112017012811A2 (pt) 2018-04-10
US10682334B2 (en) 2020-06-16
US20190314328A1 (en) 2019-10-17
JP2018500318A (ja) 2018-01-11

Similar Documents

Publication Publication Date Title
HUS2500001I1 (hu) Antitestkészítmények daganatkezelésre
IL259133A (en) Jamkaban combinations for the treatment of cardiovascular disease
SG11201701723XA (en) Methods of treating liver disease
SI3122358T1 (sl) Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka
IL252138A0 (en) Nutrient fatty acid composition is optimized
EP3132795A4 (en) Composition for preventing or treating fatty liver diseases
SI3164394T1 (sl) GLS1 inhibitorji za zdravljenje bolezni
ZA201606199B (en) Compositions and methods for treating diabetes and liver diseases
IL246721B (en) History of 5-benzylisoquinoline for the treatment of cardiovascular diseases
IL252992B (en) Grape products for non-alcoholic fatty liver disease and other uses
SG10201912638VA (en) Emulsion composition for skin
SG11201609522TA (en) Methods for treating cardiovascular diseases
IL277377B (en) Prohemostatic proteins for the treatment of bleeding
SG11201507181YA (en) Method for the treatment of fatty liver disease
BR112017012811A2 (pt) novo tratamento para doenças hepáticas gordurosas não alcoólicas
IL252707B (en) Compositions and methods for treating diseases
ZA201704589B (en) Compounds for the treatment of cancer
GB201622116D0 (en) Treatment of liver disease
GB201509781D0 (en) Non-alcoholic fatty liver disease
GB201418272D0 (en) Composition & methods of treatment
GB201418268D0 (en) Composition & methods of treatment